Mesenchymal Stem Cells Market Size, Share & Trends Analysis Report By Product & Services, By Workflow, By Type, By Source Of Isolation, By Indication, By Application, By Region, And Segment Forecasts, 2023 - 2030

Report
150 Pages
May 2023
Region: Global
Grand View Research
ID: 5415526

The global mesenchymal stem cells market size is expected to reach USD 7.21 billion by 2030. The market is expected to reach at a CAGR of 12.8% from 2023 to 2030. An exponential increase in Mesenchymal Stem Cell (MSC) based research and its implications in the field of regenerative medicine is anticipated to fuel the industry expansion. Moreover, the constantly evolving landscape of cell therapies is also anticipated to propel investments in the mesenchymal stem cells market space; large-scale operational firms are targeting small or emerging players with an operating strategy of acquisition to bolster their market presence.

The strong pipeline of mesenchymal stem cell-based products coupled with emerging applications of mesenchymal stem cells is anticipated to accelerate the industry growth. For instance, in 2022, the U. S.FDA has approved around 19 stem cell therapies for range of life-threatening disorders. Some of these therapies include, BREYANZI of BMS, ALLOCORD, KYMIRAH of Novartis etc. Moreover, a substantial number of companies are exploring the potential of MSCs as therapeutic regime for the management of inflammatory conditions, in turn, boosting market growth.

For instance, on January 2022, the Century Therapeutics and Bristol Myers Squibb entered a collaboration to expand IPSC-derives allogenic cell therapies. In addition, Takeda/TiGenix phase 3 clinical trial incorporated mesenchymal stem cells for complex perianal fistulas in Crohn's Disease. This was the most successful late-stage clinical trial as of September 2020. In addition, in August 2022 AGC Biologics partnered with human mesenchymal stem cell supplier, RoosterBio Inc. to deliver clinically proven advanced therapies for life-threatening conditions. These factors are projected to bolster the usage of stem cell products offered by key entities, thereby intensifying the market competition.

Market players are focused on the expansion of their offerings through extensive R&D and the formation of alliances and partnerships with other major players to sustain their market position. Owing to the recent pandemic of COVID-19, several research and academic research institutes are making focused efforts to develop a treatment regime by using mesenchymal stem cells.

Mesenchymal Stem Cells Market Report Highlights

The products segment dominated the segment and accounted for the largest revenue share of 78.8% in 2022. Among the products, the cells and cell lines segment has emerged as a key contributor to the segment’s revenue
Based on workflow type, the culture and cryopreservation segment dominated the industry with revenue share of 44.5% in 2022. The segment growth is attributed to the high demand for cryopreservation services and enhancement of healthcare infrastructure in developing economies
The allogenic MSCs segment accounted for the higher revenue share of 56.6% in 2022. This is attributed to the high safety profile of allogeneic mesenchymal stem cells in clinical applications
The bone marrow segment dominated the market and accounted for the largest revenue share of 24.52% in 2022. Bone marrow is a major source of isolation for mesenchymal cells
The disease modelling application segment dominated the application and accounted for the largest revenue share of 35.1% in 2022. The use of cellular disease models with patient specific MSCs provides an ideal tool for pathological research
North America dominated the market and accounted for the largest revenue share of 44.28% in 2022. The higher revenue share of the region is accounted to supportive government legislation and rising application of cell therapies in chronic disorders

This product will be delivered within 1-3 business days.

Chapter 1. Methodology and Scope

1.1. Information Procurement
1.2. Information Or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, By Company Market Share
1.4.2. Regional Analysis

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Expanding pipeline and clinical studies of mesenchymal stem cell based products
3.2.1.2. Emerging applications of MSCs
3.2.1.3. Rising market competition among key players
3.2.2. Market Restraint Analysis
3.2.2.1. Lack of standardized & regulated delivery of stem cell therapy
3.2.2.2. Ethical & safety concerns controversies associated with human msc therapy
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis

Chapter 4. Product & Services Business Analysis

4.1. Mesenchymal Stem Cells (MSCs) Market: Product & Services Movement Analysis
4.2. By Product
4.2.1. Mesenchymal Stem Cells Product Market 2018 - 2030, (USD Million)
4.2.2. Cells & Cell Lines
4.2.2.1. Cells and Cell Lines Market, 2018 - 2030 (USD Million)
4.2.3. Kits, Media & Reagents
4.2.3.1. Kits, Media & Reagents Market, 2018 - 2030 (USD Million)
4.2.4. Others
4.2.4.1. Others Market, 2018 - 2030 (USD Million)
4.3. Services
4.3.1. Mesenchymal Stem Cell Services Market, 2018 - 2030 (USD Million)

Chapter 5. Workflow Type Business Analysis

5.1. Mesenchymal Stem Cells (MSCs) Market: Workflow Type Movement Analysis
5.2. Cell Sourcing & Isolation
5.2.1. Cell Sourcing & Isolation Market, 2018 - 2030 (USD Million)
5.3. Culture & Cryopreservation
5.3.1. Culture & Cryopreservation Market, 2018 - 2030 (USD Million)
5.4. Differentiation
5.4.1. Differentiation Market, 2018 - 2030 (USD Million)
5.5. Characterization
5.5.1. Characterization Market, 2018 - 2030 (USD Million)

Chapter 6. Type Business Analysis

6.1. Mesenchymal Stem Cells (MSCs) Market: Type Movement Analysis
6.2. Autologous
6.2.1. Autologous Market, 2018 - 2030 (USD Million)
6.3. Allogeneic
6.3.1. Allogenic Market, 2018 - 2030 (USD Million)

Chapter 7. Source of Isolation Business Analysis

7.1. Mesenchymal Stem Cells (MSCs) Market: Source of Isolation Movement Analysis
7.2. Bone Marrow
7.2.1. Bone Marrow Market, 2018 - 2030 (USD Million)
7.3. Cord Blood
7.3.1. Cord blood Market, 2018 - 2030 (USD Million)
7.4. Peripheral Blood
7.4.1. Peripheral Blood Market, 2018 - 2030 (USD Million)
7.5. Fallopian Tube
7.5.1. Fallopian Tube Market, 2018 - 2030 (USD Million)
7.6. Fetal Liver
7.6.1. Fetal Liver Market, 2018 - 2030 (USD Million)
7.7. Lung
7.7.1. Lung Market, 2018 - 2030 (USD Million)
7.8. Adipose Tissue
7.8.1. Adipose Tissue Market, 2018 - 2030 (USD Million)

Chapter 8. Indication Business Analysis

8.1. Mesenchymal Stem Cells (MSCs) Market: Indication Movement Analysis
8.2. Bone & Cartilage Repair
8.2.1. Bone & Cartilage Repair Market, 2018 - 2030 (USD Million)
8.3. Cardiovascular Diseases
8.3.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Million)
8.4. Inflammatory And Immunological Diseases
8.4.1. Inflammatory And Immunological Diseases Market, 2018 - 2030 (USD Million)
8.5. Liver Diseases
8.5.1. Liver Diseases Market, 2018 - 2030 (USD Million)
8.6. Cancer
8.6.1. Cancer Market, 2018 - 2030 (USD Million)
8.7. GvHD
8.7.1. GvHD Market, 2018 - 2030 (USD Million)
8.8. Others
8.8.1. GvHD Market, 2018 - 2030 (USD Million)

Chapter 9. Application Business Analysis

9.1. Mesenchymal Stem Cells (MSCs) Market: Application Movement Analysis
9.2. Disease Modeling
9.2.1. Disease Modeling Market, 2018 - 2030 (USD Million)
9.3. Drug Development & Discovery
9.3.1. Drug Development & Discovery Market, 2018 - 2030 (USD Million)
9.4. Stem Cell Banking
9.4.1. Stem Cell Banking Market, 2018 - 2030 (USD Million)
9.5. Tissue Engineering
9.5.1. Tissue Engineering Market, 2018 - 2030 (USD Million)
9.6. Toxicology Studies
9.6.1. Toxicology Studies Market, 2018 - 2030 (USD Million)
9.7. Others
9.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 10. Regional Business Analysis

10.1. Mesenchymal Stem Cells Market Share By Region, 2022 & 2030
10.2. North America
10.2.1. SWOT Analysis
10.2.2. North America Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
10.2.3. U.S.
10.2.3.1. Key Country Dynamics
10.2.3.2. Target Disease Prevalence
10.2.3.3. Competitive Scenario
10.2.3.4. U.S. Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
10.2.4. Canada
10.2.4.1. Key Country Dynamics
10.2.4.2. Target Disease Prevalence
10.2.4.3. Competitive Scenario
10.2.4.4. Canada Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
10.3. Europe
10.3.1. SWOT Analysis
10.3.2. Europe Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
10.3.3. UK
10.3.3.1. Key Country Dynamics
10.3.3.2. Target Disease Prevalence
10.3.3.3. Competitive Scenario
10.3.3.4. UK Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
10.3.4. Germany
10.3.4.1. Key Country Dynamics
10.3.4.2. Target Disease Prevalence
10.3.4.3. Competitive Scenario
10.3.4.4. Germany Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
10.3.5. France
10.3.5.1. Key Country Dynamics
10.3.5.2. Target Disease Prevalence
10.3.5.3. Competitive Scenario
10.3.5.4. France Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
10.3.6. Italy
10.3.6.1. Key Country Dynamics
10.3.6.2. Target Disease Prevalence
10.3.6.3. Competitive Scenario
10.3.6.4. Italy Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
10.3.7. Spain
10.3.7.1. Key Country Dynamics
10.3.7.2. Target Disease Prevalence
10.3.7.3. Competitive Scenario
10.3.7.4. Spain Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
10.3.8. Denmark
10.3.8.1. Key Country Dynamics
10.3.8.2. Target Disease Prevalence
10.3.8.3. Competitive Scenario
10.3.8.4. Denmark Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
10.3.9. Sweden
10.3.9.1. Key Country Dynamics
10.3.9.2. Target Disease Prevalence
10.3.9.3. Competitive Scenario
10.3.9.4. Sweden Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
10.3.10. Norway
10.3.10.1. Key Country Dynamics
10.3.10.2. Target Disease Prevalence
10.3.10.3. Competitive Scenario
10.3.10.4. Norway Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
10.4. Asia Pacific
10.4.1. SWOT Analysis
10.4.2. Asia Pacific Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
10.4.3. Japan
10.4.3.1. Key Country Dynamics
10.4.3.2. Target Disease Prevalence
10.4.3.3. Competitive Scenario
10.4.3.4. Japan Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
10.4.4. China
10.4.4.1. Key Country Dynamics
10.4.4.2. Target Disease Prevalence
10.4.4.3. Competitive Scenario
10.4.4.4. China Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
10.4.5. India
10.4.5.1. Key Country Dynamics
10.4.5.2. Target Disease Prevalence
10.4.5.3. Competitive Scenario
10.4.5.4. India Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
10.4.6. Australia
10.4.6.1. Key Country Dynamics
10.4.6.2. Target Disease Prevalence
10.4.6.3. Competitive Scenario
10.4.6.4. Australia Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
10.4.7. Thailand
10.4.7.1. Key Country Dynamics
10.4.7.2. Target Disease Prevalence
10.4.7.3. Competitive Scenario
10.4.7.4. Thailand Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
10.4.8. South Korea
10.4.8.1. Key Country Dynamics
10.4.8.2. Target Disease Prevalence
10.4.8.3. Competitive Scenario
10.4.8.4. South Korea Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
10.5. Latin America
10.5.1. SWOT Analysis
10.5.2. Latin America Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
10.5.3. Brazil
10.5.3.1. Key Country Dynamics
10.5.3.2. Target Disease Prevalence
10.5.3.3. Competitive Scenario
10.5.3.4. Brazil Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
10.5.4. Mexico
10.5.4.1. Key Country Dynamics
10.5.4.2. Target Disease Prevalence
10.5.4.3. Competitive Scenario
10.5.4.4. Mexico Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
10.5.5. Argentina
10.5.5.1. Key Country Dynamics
10.5.5.2. Target Disease Prevalence
10.5.5.3. Competitive Scenario
10.5.5.4. Argentina Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
10.6. MEA
10.6.1. SWOT Analysis
10.6.2. MEA Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
10.6.3. South Africa
10.6.3.1. Key Country Dynamics
10.6.3.2. Target Disease Prevalence
10.6.3.3. Competitive Scenario
10.6.3.4. South Africa Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
10.6.4. Saudi Arabia
10.6.4.1. Key Country Dynamics
10.6.4.2. Target Disease Prevalence
10.6.4.3. Competitive Scenario
10.6.4.4. Saudi Arabia Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
10.6.5. UAE
10.6.5.1. Key Country Dynamics
10.6.5.2. Target Disease Prevalence
10.6.5.3. Competitive Scenario
10.6.5.4. UAE Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
10.6.6. Kuwait
10.6.6.1. Key Country Dynamics
10.6.6.2. Target Disease Prevalence
10.6.6.3. Competitive Scenario
10.6.6.4. Kuwait Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)

Chapter 11. Competitive Landscape

11.1. Company Categorization
11.2. Strategy Mapping
11.3. Company Market Share Analysis, 2022
11.4. Company Profiles/Listing
11.4.1. Thermo Fisher Scientific, Inc.
11.4.1.1. Overview
11.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.1.3. Product Benchmarking
11.4.1.4. Strategic Initiatives
11.4.2. Cell Applications, Inc.
11.4.2.1. Overview
11.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.2.3. Product Benchmarking
11.4.2.4. Strategic Initiatives
11.4.3. Cyagen Biosciences
11.4.3.1. Overview
11.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.3.3. Product Benchmarking
11.4.3.4. Strategic Initiatives
11.4.4. Axol Bioscience Ltd.
11.4.4.1. Overview
11.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.4.3. Product Benchmarking
11.4.4.4. Strategic Initiatives
11.4.5. STEMCELL Technologies
11.4.5.1. Overview
11.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.5.3. Product Benchmarking
11.4.5.4. Strategic Initiatives
11.4.6. Celprogen Inc.
11.4.6.1. Overview
11.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.6.3. Product Benchmarking
11.4.6.4. Strategic Initiatives
11.4.7. BrainStorm Cell Limited
11.4.7.1. Overview
11.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.7.3. Product Benchmarking
11.4.7.4. Strategic Initiatives
11.4.8. Stemedica Cell Technologies, Inc.
11.4.8.1. Overview
11.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.8.3. Product Benchmarking
11.4.8.4. Strategic Initiatives
11.4.9. Merck KGaA
11.4.9.1. Overview
11.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.9.3. Product Benchmarking
11.4.9.4. Strategic Initiatives
11.4.10. Lonza
11.4.10.1. Overview
11.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.10.3. Product Benchmarking
11.4.10.4. Strategic Initiatives
11.4.11. PromoCell GmbH
11.4.11.1. Overview
11.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.11.3. Product Benchmarking
11.4.11.4. Strategic Initiatives

List of Tables

Table 1 List of abbreviations
Table 2 Global mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 3 Global mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 4 Global mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 5 Global mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 6 Global mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 7 Global mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
Table 8 Global mesenchymal stem cells market, by region, 2018 - 2030 (USD Million)
Table 9 North America mesenchymal stem cells market, by country, 2018 - 2030 (USD Million)
Table 10 North America mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 11 North America mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 12 North America mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 13 North America mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 14 North America mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 15 North America mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
Table 16 U.S. mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 17 U.S. mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 18 U.S. mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 19 U.S. mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 20 U.S. mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 21 U.S. mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
Table 22 Canada mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 23 Canada mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 24 Canada mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 25 Canada mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 26 Canada mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 27 Canada mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
Table 28 Europe mesenchymal stem cells market, by country, 2018 - 2030 (USD Million)
Table 29 Europe mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 30 Europe mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 31 Europe mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 32 Europe mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 33 Europe mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 34 Europe mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
Table 35 UK mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 36 UK mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 37 UK mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 38 UK mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 39 UK mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 40 UK mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
Table 41 Germany mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 42 Germany mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 43 Germany mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 44 Germany mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 45 Germany mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 46 Germany mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
Table 47 France mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 48 France mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 49 France mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 50 France mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 51 France mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 52 France mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
Table 53 Italy mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 54 Italy mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 55 Italy mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 56 Italy mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 57 Italy mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 58 Italy mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
Table 59 Spain mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 60 Spain mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 61 Spain mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 62 Spain mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 63 Spain mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 64 Spain mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
Table 65 Denmark mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 66 Denmark mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 67 Denmark mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 68 Denmark mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 69 Denmark mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 70 Denmark mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
Table 71 Norway mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 72 Norway mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 73 Norway mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 74 Norway mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 75 Norway mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 76 Norway mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
Table 77 Sweden mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 78 Sweden mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 79 Sweden mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 80 Sweden mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 81 Sweden mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 82 Sweden mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
Table 83 Asia Pacific mesenchymal stem cells market, by country, 2018 - 2030 (USD Million)
Table 84 Asia Pacific mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 85 Asia Pacific mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 86 Asia Pacific mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 87 Asia Pacific mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 88 Asia Pacific mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 89 Asia Pacific mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
Table 90 Japan mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 91 Japan mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 92 Japan mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 93 Japan mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 94 Japan mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 95 Japan mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
Table 96 China mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 97 China mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 98 China mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 99 China mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 100 China mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 101 China mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
Table 102 India mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 103 India mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 104 India mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 105 India mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 106 India mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 107 India mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
Table 108 Australia mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 109 Australia mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 110 Australia mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 111 Australia mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 112 Australia mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 113 Australia mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
Table 114 Thailand mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 115 Thailand mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 116 Thailand mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 117 Thailand mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 118 Thailand mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 119 Thailand mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
Table 120 South Korea mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 121 South Korea mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 122 South Korea mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 123 South Korea mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 124 South Korea mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 125 South Korea mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
Table 126 Latin America mesenchymal stem cells market, by country, 2018 - 2030 (USD Million)
Table 127 Latin America mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 128 Latin America mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 129 Latin America mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 130 Latin America mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 131 Latin America mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 132 Latin America mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
Table 133 Brazil mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 134 Brazil mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 135 Brazil mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 136 Brazil mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 137 Brazil mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 138 Brazil mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
Table 139 Mexico mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 140 Mexico mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 141 Mexico mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 142 Mexico mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 143 Mexico mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 144 Mexico mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
Table 145 Argentina mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 146 Argentina mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 147 Argentina mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 148 Argentina mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 149 Argentina mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 150 Argentina mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
Table 151 Middle East & Africa mesenchymal stem cells market, by country, 2018 - 2030 (USD Million)
Table 152 Middle East & Africa mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 153 Middle East & Africa mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 154 Middle East & Africa mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 155 Middle East & Africa mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 156 Middle East & Africa mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 157 Middle East & Africa mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
Table 158 South Africa mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 159 South Africa mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 160 South Africa mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 161 South Africa mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 162 South Africa mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 163 South Africa mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
Table 164 Saudi Arabia mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 165 Saudi Arabia mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 166 Saudi Arabia mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 167 Saudi Arabia mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 168 Saudi Arabia mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 169 Saudi Arabia mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
Table 170 UAE mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 171 UAE mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 172 UAE mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 173 UAE mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 174 UAE mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 175 UAE mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
Table 176 Argentina mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
Table 177 Kuwait mesenchymal stem cells market, by workflow, 2018 - 2030 (USD Million)
Table 178 Kuwait mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
Table 179 Kuwait mesenchymal stem cells market, by source of application, 2018 - 2030 (USD Million)
Table 180 Kuwait mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
Table 181 Kuwait mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 mesenchymal stem cells market segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 PESTEL analysis
Fig. 13 Porter’s five forces analysis
Fig. 14 Global mesenchymal stem cells market: Product & services movement analysis
Fig. 15 Global mesenchymal stem cells market, for products, 2018 - 2030 (USD Million)
Fig. 16 Global mesenchymal stem cells market, for cells and cell lines, 2018 - 2030 (USD Million)
Fig. 17 Global mesenchymal stem cells market, for kits, media & reagents, 2018 - 2030 (USD Million)
Fig. 18 Global mesenchymal stem cells market, for others, 2018 - 2030 (USD Million)
Fig. 19 Global mesenchymal stem cells market, for Services, 2018 - 2030 (USD Million)
Fig. 20 Global mesenchymal stem cells market: Workflow movement analysis
Fig. 21 Global mesenchymal stem cells market, for cell Sourcing & Isolation, 2018 - 2030 (USD Million)
Fig. 22 Global mesenchymal stem cells market, for culture & Cryopreservation, 2018 - 2030 (USD Million)
Fig. 23 Global mesenchymal stem cells market, for differentiation, 2018 - 2030 (USD Million)
Fig. 24 Global mesenchymal stem cells market, for characterization, 2018 - 2030 (USD Million)
Fig. 25 Global mesenchymal stem cells market: Type movement analysis
Fig. 26 Global mesenchymal stem cells market, for autologous, 2018 - 2030 (USD Million)
Fig. 27 Global mesenchymal stem cells market, for allogenic, 2018 - 2030 (USD Million)
Fig. 28 Global mesenchymal stem cells market: Source of isolation movement analysis
Fig. 29 Global mesenchymal stem cells market, for bone Marrow, 2018 - 2030 (USD Million)
Fig. 30 Global mesenchymal stem cells market, for cord Blood, 2018 - 2030 (USD Million)
Fig. 31 Global mesenchymal stem cells market, for peripheral Blood, 2018 - 2030 (USD Million)
Fig. 32 Global mesenchymal stem cells market, for fallopian Tube, 2018 - 2030 (USD Million)
Fig. 33 Global mesenchymal stem cells market, for fetal Liver, 2018 - 2030 (USD Million)
Fig. 34 Global mesenchymal stem cells market, for lung, 2018 - 2030 (USD Million)
Fig. 35 Global mesenchymal stem cells market, for adipose Tissues, 2018 - 2030 (USD Million)
Fig. 36 Global mesenchymal stem cells market: Indication movement analysis
Fig. 37 Global mesenchymal stem cells market, for bone And Cartilage Repair, 2018 - 2030 (USD Million)
Fig. 38 Global mesenchymal stem cells market, for cardiovascular Diseases, 2018 - 2030 (USD Million)
Fig. 39 Global mesenchymal stem cells market, for Inflammatory And Immunological Diseases, 2018 - 2030 (USD Million)
Fig. 40 Global mesenchymal stem cells market, for liver Diseases, 2018 - 2030 (USD Million)
Fig. 41 Global mesenchymal stem cells market, for cancer, 2018 - 2030 (USD Million)
Fig. 42 Global mesenchymal stem cells market, for GvHD, 2018 - 2030 (USD Million)
Fig. 43 Global mesenchymal stem cells market, for others, 2018 - 2030 (USD Million)
Fig. 44 Global mesenchymal stem cells market: Application movement analysis
Fig. 45 Global mesenchymal stem cells market, for disease modeling, 2018 - 2030 (USD Million)
Fig. 46 Global mesenchymal stem cells market, for drug development & discovery, 2018 - 2030 (USD Million)
Fig. 47 Global mesenchymal stem cells market, for stem cell banking, 2018 - 2030 (USD Million)
Fig. 48 Global mesenchymal stem cells market, for tissue engineering, 2018 - 2030 (USD Million)
Fig. 49 Global mesenchymal stem cells market, for toxicology studies, 2018 - 2030 (USD Million)
Fig. 50 Global mesenchymal stem cells market, for others, 2018 - 2030 (USD Million)
Fig. 51 Regional marketplace: Key takeaways
Fig. 52 Regional outlook, 2022 & 2030
Fig. 53 Global mesenchymal stem cells market: Region movement analysis
Fig. 54 North America mesenchymal stem cells market, 2018 - 2030 (USD Million)
Fig. 55 U.S. mesenchymal stem cells market, 2018 - 2030 (USD Million)
Fig. 56 Canada mesenchymal stem cells market, 2018 - 2030 (USD Million)
Fig. 57 Europe mesenchymal stem cells market, 2018 - 2030 (USD Million)
Fig. 58 Germany mesenchymal stem cells market, 2018 - 2030 (USD Million)
Fig. 59 UK mesenchymal stem cells market, 2018 - 2030 (USD Million)
Fig. 60 France mesenchymal stem cells market, 2018 - 2030 (USD Million)
Fig. 61 Italy mesenchymal stem cells market, 2018 - 2030 (USD Million)
Fig. 62 Spain mesenchymal stem cells market, 2018 - 2030 (USD Million)
Fig. 63 Denmark mesenchymal stem cells market, 2018 - 2030 (USD Million)
Fig. 64 Sweden mesenchymal stem cells market, 2018 - 2030 (USD Million)
Fig. 65 Norway mesenchymal stem cells market, 2018 - 2030 (USD Million)
Fig. 66 Asia Pacific mesenchymal stem cells market, 2018 - 2030 (USD Million)
Fig. 67 Japan mesenchymal stem cells market, 2018 - 2030 (USD Million)
Fig. 68 China mesenchymal stem cells market, 2018 - 2030 (USD Million)
Fig. 69 India mesenchymal stem cells market, 2018 - 2030 (USD Million)
Fig. 70 Australia mesenchymal stem cells market, 2018 - 2030 (USD Million)
Fig. 71 South Korea mesenchymal stem cells market, 2018 - 2030 (USD Million)
Fig. 72 Thailand mesenchymal stem cells market, 2018 - 2030 (USD Million)
Fig. 73 Latin America mesenchymal stem cells market, 2018 - 2030 (USD Million)
Fig. 74 Brazil mesenchymal stem cells market, 2018 - 2030 (USD Million)
Fig. 75 Mexico mesenchymal stem cells market, 2018 - 2030 (USD Million)
Fig. 76 Argentina mesenchymal stem cells market, 2018 - 2030 (USD Million)
Fig. 77 Middle East and Africa mesenchymal stem cells market, 2018 - 2030 (USD Million)
Fig. 78 South Africa mesenchymal stem cells market, 2018 - 2030 (USD Million)
Fig. 79 Saudi Arabia mesenchymal stem cells market, 2018 - 2030 (USD Million)
Fig. 80 UAE mesenchymal stem cells market, 2018 - 2030 (USD Million)
Fig. 81 Kuwait mesenchymal stem cells market, 2018 - 2030 (USD Million)

Companies Mentioned

Thermo Fisher Scientific, Inc.
Cell Applications, Inc.
Cyagen Biosciences
Axol Bioscience Ltd.
STEMCELL Technologies
Celprogen Inc.
BrainStorm Cell Limited
Stemedica Cell Technologies, Inc.
Merck KGaA
Lonza
PromoCell GmbH

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	150
Published	May 2023
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 2.7 Billion
Forecasted Market Value ( USD ) by 2030	$ 7.21 Billion
Compound Annual Growth Rate	12.8%
Regions Covered	Global
No. of Companies Mentioned	11

PURCHASE OPTIONS

Single User License PDF

1 - 5 User License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5779EUR$5,950USD£4,985GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€6750EUR$6,950USD£5,823GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€8693EUR$8,950USD£7,499GBP

Mesenchymal Stem Cells Market Report Highlights

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Mesenchymal Stem Cells Market by Type (Allogeneic, Autologous), Indication (Bone & Cartilage Repair, Cancer, Cardiovascular Disease), Source of Isolation, Application - Forecast 2023-2030

Mesenchymal Stem Cell Market Report: Trends, Forecast and Competitive Analysis to 2030

Global Mesenchymal Stem Cells Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

Mesenchymal Stem Cells (MSC): Global Strategic Business Report

Mesenchymal Stem Cell Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type